Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.26) per share. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year.
Verizon Clocks 4% Sales Growth In Q3, Expects Customer Disconnect Pressure Due To Pricing Actions
Verizon Communications Inc (NYSE:VZ) reported a third-quarter FY22 sales growth of 4% year-on-year to $34.2 billion, beating the consensus of…
